slno,preds
0,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key details:

1. **Tumor Characteristics**:
   - There are two distinct adenocarcinomas: 
     - A 1 cm solid predominant adenocarcinoma in the lingula.
     - A 3.5 cm micropapillary predominant adenocarcinoma in the left lower lobe.
   - Both tumors have free margins, indicating that the surgical resection was complete with no residual tumor at the margins.

2. **Lymph Node Involvement**:
   - There is no lymph node metastasis, which is a favorable prognostic factor as it suggests the cancer has not spread to the lymphatic system.

3. **Molecular Findings**:
   - A positive KRAS mutation is present, which is generally associated with a poorer prognosis and potential resistance to certain therapies.
   - No EGFR mutations were detected, which limits the use of targeted therapies that are effective in EGFR-mutated cancers.

4. **Additional Findings**:
   - The presence of emphysema is noted, which may affect overall lung function but is not directly related to cancer prognosis.
   - The tumors are considered morphologically distinct, suggesting they may represent separate primary cancers rather than metastatic spread.

5. **Overall Assessment**:
   - The absence of lymph node metastasis and clear surgical margins are positive indicators for survival.
   - The presence of a KRAS mutation is a negative prognostic factor, but it does not definitively predict survival outcomes within the specified timeframe.
   - The presence of two separate primary tumors complicates the prognosis but does not inherently indicate a poor short-term survival outcome.

Considering these factors, while the KRAS mutation suggests a poorer prognosis, the lack of lymph node involvement and clear margins are strong positive indicators. Therefore, the likelihood of survival after 2.48 years is reasonably favorable.

Answer - {""Survival"": ""True""}"
1,"The pathology report provides the following key details:

1. **Lymph Node Status**: Multiple lymph nodes were biopsied and all were negative for neoplasm, indicating no lymph node metastasis.

2. **Tumor Characteristics**: The tumor is a moderately differentiated adenocarcinoma, which generally suggests a moderate prognosis compared to poorly differentiated tumors.

3. **Tumor Size and Invasion**: The tumor measures 2.0 x 2.0 x 1.6 cm, which is relatively small. There is focal pleural invasion, but no lymphovascular space invasion, which is a positive factor as lymphovascular invasion often indicates a higher risk of metastasis.

4. **Staging**: The tumor is staged as T2N0. T2 indicates a tumor size greater than 3 cm but less than 5 cm, or a tumor with certain features such as invasion into the visceral pleura. N0 indicates no regional lymph node involvement.

Given these factors, the absence of lymph node involvement (N0) and the lack of lymphovascular invasion are favorable prognostic indicators. The focal pleural invasion is a concern, but the overall staging of T2N0 suggests a localized disease without lymph node spread, which generally has a better prognosis.

Based on these considerations, it is reasonable to conclude that the patient has a good chance of surviving beyond 2.48 years.

Answer - {""Survival"": ""True""}"
2,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key details:

1. **Tumor Characteristics**:
   - The tumor is an adenocarcinoma with a lepidic pattern, which is generally associated with a better prognosis compared to other patterns.
   - It measures 2.8 cm, which falls under the T1b category (tumor size greater than 2 cm but not more than 3 cm).
   - The tumor is well-differentiated and minimally invasive, indicating a less aggressive form of cancer.

2. **Surgical Margins**:
   - The surgical margins are negative, meaning the tumor was completely resected with no cancer cells at the edges of the removed tissue, reducing the risk of recurrence.

3. **Invasion and Metastasis**:
   - There is no evidence of lymphovascular invasion or visceral pleura invasion, suggesting limited spread of the cancer.
   - Lymph node examinations from various sites showed no malignancy, indicating no regional lymph node metastasis.

4. **Staging**:
   - The cancer is staged as pT1b, pN1. The pN1 staging indicates that there is some involvement of regional lymph nodes, but given the absence of malignancy in sampled nodes, this might be a minimal involvement or a potential error in the report.

5. **Overall Prognosis**:
   - The combination of a well-differentiated, minimally invasive tumor with negative margins and no lymphovascular or visceral pleura invasion suggests a favorable prognosis.
   - The absence of malignancy in lymph nodes further supports a positive outlook.

Based on these factors, the patient is likely to have a good chance of survival beyond 2.48 years. Therefore, the answer is:

{""Survival"": ""True""}"
3,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Tumor Differentiation**: The adenocarcinoma is described as moderately-poorly differentiated. Poor differentiation generally indicates a more aggressive tumor with a worse prognosis compared to well-differentiated tumors.

2. **Tumor Size**: The tumor measures 2.5 x 2.0 cm, which is relatively small. However, size alone is not the only factor in determining prognosis.

3. **Lymph Node Involvement**: Out of twelve examined lymph nodes, ten are involved with metastatic carcinoma, including the subcarinal lymph node. This indicates significant lymph node involvement, which is a poor prognostic factor as it suggests the cancer has spread beyond the primary site.

4. **Surgical Margins**: The surgical margins are negative for tumor, which is a positive finding, indicating that the tumor was completely resected.

5. **Lymphovascular Invasion**: There is extensive lymphovascular invasion noted within the lung tissue. This is another poor prognostic factor, as it suggests that the cancer has the potential to spread through the lymphatic and vascular systems.

Considering these factors, the extensive lymph node involvement and lymphovascular invasion are significant indicators of a poor prognosis. Despite the negative surgical margins, the aggressive nature of the tumor and its spread to multiple lymph nodes suggest a high likelihood of recurrence or progression within 2.48 years.

Therefore, the likelihood of survival after 2.48 years is low.

Answer - {""Survival"": ""False""}"
4,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Tumor Characteristics**: The patient has an invasive poorly differentiated adenocarcinoma in the left upper lobe of the lung, measuring 2.7 cm. Poor differentiation generally indicates a more aggressive tumor, which can negatively impact prognosis.

2. **Visceral Pleura Invasion**: The tumor invades the visceral pleura. Pleural invasion is associated with a higher stage of cancer and can be a negative prognostic factor.

3. **Intratumoral Large Vessel Invasion**: The presence of large vessel invasion is a significant adverse prognostic factor, as it suggests a higher likelihood of metastasis and aggressive tumor behavior.

4. **Lymph Node Status**: The level 5 lymph node resection revealed anthracotic lymph nodes that were negative for metastatic carcinoma. The absence of lymph node metastasis is a positive prognostic factor.

5. **Staging**: The tumor is staged as pT2a, which indicates a tumor size greater than 3 cm but less than or equal to 5 cm, with invasion into the visceral pleura but no lymph node involvement (N0) or distant metastasis (M0). This stage suggests localized disease, which is generally more favorable than advanced stages.

6. **Parenchymal Margin**: The tumor has a parenchymal margin of 8 mm, indicating that the surgical resection was successful in removing the tumor with a clear margin, which is a positive factor for prognosis.

7. **No Distant Metastasis**: The absence of distant metastasis is a positive prognostic factor.

Considering these factors, the presence of poorly differentiated histology and large vessel invasion are significant negative prognostic indicators. However, the absence of lymph node involvement and distant metastasis, along with a clear surgical margin, are positive factors. The balance of these factors suggests a guarded prognosis, but the absence of metastasis and clear margins may allow for a reasonable chance of survival beyond 2.48 years, depending on additional treatments and patient factors.

Answer - {""Survival"": ""True""}"
5,"The pathology report provides the following key information:

1. **Diagnosis**: Invasive mucinous adenocarcinoma in the right upper lobe of the lung.
2. **Tumor Size**: 2.5 cm.
3. **Margins**: Clear margins with no residual tumor after completion lobectomy.
4. **Lymph Nodes**: All examined lymph nodes (levels 4, 7, and 10) are negative for carcinoma, indicating no regional lymph node metastasis.
5. **Molecular Studies**: Positive KRAS mutation (p.G12C) and no EGFR mutations, suggesting a potential for poor prognosis and resistance to certain therapies.

**Analysis**:
- The tumor is relatively small (2.5 cm) and has been completely resected with clear margins, which is a positive factor for prognosis.
- The absence of lymph node metastasis is another favorable prognostic factor, as it indicates localized disease without regional spread.
- The presence of a KRAS mutation (p.G12C) is associated with a poorer prognosis and potential resistance to certain targeted therapies, which could negatively impact survival.

**Conclusion**:
Despite the presence of a KRAS mutation, the overall pathology report suggests a favorable prognosis due to the small tumor size, clear surgical margins, and absence of lymph node involvement. These factors generally indicate a higher likelihood of survival beyond 2.48 years.

Answer - {""Survival"": ""True""}"
6,"The pathology report provides the following key details:

1. **Invasive Grade 3 Adenocarcinoma**: This indicates a high-grade tumor, which generally suggests a more aggressive cancer with a poorer prognosis.

2. **Tumor Size and Margins**: The tumor measures 5 x 4 x 3 cm, and the bronchial margins are negative, indicating that the surgical resection was complete with no residual tumor at the margins.

3. **Lymph Node Involvement**: One of six intrapulmonary peribronchial lymph nodes tested positive for metastatic adenocarcinoma. This indicates regional lymph node involvement, which is a negative prognostic factor.

4. **Necrotizing Granuloma and Granulomatous Lymphadenitis**: The wedge excision of the right upper lobe showed necrotizing granuloma, and multiple lymph nodes from the mediastinum were involved with necrotizing granulomatous lymphadenitis but were negative for tumor. This suggests an inflammatory or infectious process, not directly related to the cancer.

5. **Special Stains for Microorganisms**: These were negative, indicating no infectious organisms were identified in the subcarinal lymph nodes.

Considering these factors, the presence of metastatic adenocarcinoma in one lymph node suggests a more advanced stage of cancer, which typically correlates with a poorer prognosis. However, the absence of distant metastasis and negative bronchial margins are positive factors. The necrotizing granulomatous findings are not directly related to the cancer prognosis but may complicate the clinical picture.

Given the aggressive nature of a grade 3 adenocarcinoma and the lymph node involvement, the likelihood of survival beyond 2.48 years is reduced, although not impossible. However, based on the information provided, the prognosis leans towards a poorer outcome.

Answer - {""Survival"": ""False""}"
7,"1. **Tumor Characteristics**: The tumor is a moderately differentiated adenocarcinoma, which generally indicates a moderate prognosis compared to poorly differentiated tumors. The size of the tumor is 2.3 cm, which is relatively small.

2. **Margins and Invasion**: The carcinoma extends to within 1 mm of the staple line but does not invade the visceral pleura. This suggests that while the tumor is close to the surgical margin, it has not invaded critical structures like the pleura, which is a positive factor.

3. **Lymph Node Involvement**: No metastatic carcinoma was identified in the examined lymph nodes. This is a favorable finding, as the absence of lymph node involvement (N0) typically indicates a lower risk of metastasis and a better prognosis.

4. **Staging**: The tumor is staged as pT1b N0. This staging indicates a small, localized tumor without lymph node involvement, which is generally associated with a good prognosis.

5. **Recommendation**: Clinical correlation and follow-up are recommended, which is standard practice to monitor for any recurrence or progression.

Based on these factors, the prognosis appears favorable, and the likelihood of survival beyond 2.48 years is high.

Answer - {""Survival"": ""True""}"
8,"The pathology report provides the following key details:

1. **Tumor Characteristics**: The patient has an invasive moderately differentiated adenocarcinoma in the right upper lobe.

2. **Lymph Node Involvement**: There is metastatic involvement in one of four hilar lymph nodes. This indicates some spread of the cancer to nearby lymph nodes, which is a negative prognostic factor.

3. **Other Lymph Nodes**: Additional biopsies from various lymph nodes showed no carcinoma, which is a positive sign as it suggests limited lymph node involvement.

4. **Surgical Margins**: The surgical margins, including the bronchial resection margin, are negative for carcinoma. This is a positive factor as it indicates that the tumor was likely completely resected.

5. **Pleural and Angiolymphatic Invasion**: There is no evidence of pleural involvement or angiolymphatic invasion, which are positive prognostic factors.

Considering these factors, the presence of metastatic involvement in one lymph node suggests a more advanced stage than if there were no lymph node involvement. However, the absence of pleural and angiolymphatic invasion, along with negative surgical margins, are favorable factors. The prognosis is mixed, but given the absence of more extensive lymph node involvement and other negative factors, the patient may have a reasonable chance of survival beyond 2.48 years.

Answer - {""Survival"": ""True""}"
9,"1. **Tumor Characteristics**: The tumor is described as an invasive well-differentiated adenocarcinoma with a predominant bronchiolo-alveolar carcinoma component. Well-differentiated tumors generally have a better prognosis compared to poorly differentiated ones.

2. **Size and Location**: The tumor measures approximately 50 x 60 x 45 mm and is located in the left lower lobe. While the size is relatively large, the absence of other high-risk features is more critical in determining prognosis.

3. **Invasion and Metastasis**: There is no evidence of vascular or perineural invasion, and no metastases to hilar lymph nodes are noted. The absence of lymph node involvement and vascular invasion is a positive prognostic factor.

4. **Pleural Involvement**: Although the tumor closely abuts the pleural surface, confirmatory stains suggest that the pleura is likely not involved. Lack of pleural invasion is another favorable prognostic indicator.

5. **Additional Findings**: The separate specimen from the back shows features consistent with a lipoma, which is benign and unrelated to the malignancy.

6. **Overall Assessment**: The combination of a well-differentiated tumor, absence of lymph node metastasis, no vascular or perineural invasion, and likely no pleural involvement suggests a favorable prognosis. 

Based on these factors, it is reasonable to conclude that the patient is likely to survive beyond 2.48 years.

Answer - {""Survival"": ""True""}"
10,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Tumor Size and Differentiation**: The tumor measures 3 x 3 x 3 cm and is poorly differentiated. Poor differentiation generally indicates a more aggressive tumor with a worse prognosis compared to well-differentiated tumors.

2. **Visceral Pleura Invasion**: The tumor has invaded the visceral pleura. Pleural invasion is associated with a higher stage of cancer and can negatively impact prognosis.

3. **Lymph Node Metastasis**: Metastasis is present in 1 out of 1 examined lymph node. The presence of lymph node metastasis indicates that the cancer has started to spread beyond the primary site, which is a significant factor in determining prognosis and typically suggests a poorer outcome.

4. **Immunohistochemical Staining**: The tumor is positive for CD15, CK7, TTF1, and CEA, and negative for CK20 and CDX2. These markers are consistent with a primary lung adenocarcinoma, but they do not directly impact the prognosis in terms of survival prediction.

Considering these factors, the presence of poorly differentiated adenocarcinoma with pleural invasion and lymph node metastasis suggests a more advanced stage of cancer with a less favorable prognosis. Therefore, the likelihood of survival after 2.48 years is lower.

Answer - {""Survival"": ""False""}"
11,"The pathology report provides the following key details:

1. **Tumor Size and Type**: The tumor is located in the left lower lobe of the lung, measuring 4.0 x 3.5 x 2.0 cm, and is diagnosed as adenocarcinoma of mixed subtype, predominantly papillary.

2. **Visceral Pleura Infiltration**: There is infiltration of the visceral pleura, which can be a concerning factor as it indicates some level of local invasion.

3. **Tumor Classification**: The tumor is classified as pT2, which generally indicates a tumor size greater than 3 cm but less than or equal to 5 cm, or a tumor with certain local invasions such as visceral pleura involvement.

4. **Lymph Node Involvement**: There is no regional lymph node involvement (0/20), which is a positive prognostic factor as it suggests the cancer has not spread to nearby lymph nodes.

5. **Distant Metastasis Status**: The distant metastasis status is unknown (pMx), which means it is unclear whether the cancer has spread to distant sites.

6. **Tumor Grade**: The tumor grade is G2, indicating moderate differentiation. This suggests that the tumor cells are somewhat abnormal but not highly aggressive.

Considering these factors:

- The absence of lymph node involvement is a favorable prognostic factor.
- The moderate differentiation (G2) suggests a less aggressive tumor compared to poorly differentiated ones.
- The infiltration of the visceral pleura is a concern but does not necessarily indicate a poor prognosis on its own.
- The unknown status of distant metastasis (pMx) introduces some uncertainty, but without evidence of metastasis, the prognosis may still be relatively favorable.

Based on these considerations, the likelihood of survival after 2.48 years is reasonably positive, assuming no distant metastasis is present.

Answer - {""Survival"": ""True""}"
12,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Tumor Characteristics**: The adenocarcinoma is moderately differentiated and measures 2.7 cm. Moderately differentiated tumors generally have an intermediate prognosis compared to well-differentiated (better prognosis) and poorly differentiated (worse prognosis) tumors.

2. **Invasion and Margins**: There is no angiolymphatic invasion or pleural involvement, and the bronchial margin is negative. These are favorable findings, as they suggest the tumor has not spread extensively within the lung or to adjacent structures.

3. **Lymph Node Involvement**: Metastatic adenocarcinoma was found in 1 out of 4 peribronchial lymph nodes. However, no metastatic carcinoma was identified in the R4 and station 11 lymph nodes. The presence of metastasis in one lymph node indicates some regional spread, which can affect prognosis, but the absence of metastasis in other examined nodes is a positive sign.

4. **Surgical Margins and Additional Lesions**: The surgical margins are negative for tumor involvement, and no additional lesions were noted in the surrounding lung tissue. This suggests that the tumor was likely completely resected, which is a positive prognostic factor.

Considering these factors, the presence of metastasis in one lymph node suggests a stage that may be associated with a moderate risk of recurrence or progression. However, the absence of extensive lymph node involvement, negative surgical margins, and lack of angiolymphatic or pleural invasion are favorable factors that improve the prognosis.

Based on this analysis, the likelihood of survival after 2.48 years is relatively favorable, but not guaranteed. However, given the overall positive findings, the patient is more likely to survive beyond 2.48 years.

Answer - {""Survival"": ""True""}"
13,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key details:

1. **Tumor Size and Differentiation**: The tumor is relatively small at 1.2 cm, which is generally favorable for prognosis. However, it is classified as moderately to poorly differentiated, which can indicate a more aggressive tumor behavior.

2. **Surgical Margins**: All surgical margins are free of tumor, suggesting that the tumor was completely resected, which is a positive factor for survival.

3. **Visceral Pleura Invasion**: There is focal invasion into the visceral pleura. While this indicates some level of local invasion, it is not necessarily a definitive indicator of poor prognosis, especially if the invasion is minimal.

4. **Lymphatic Invasion**: There is a focus suggestive of lymphatic invasion, which can be concerning as it may indicate potential for metastasis. However, no lymph node involvement was detected among the seven examined, which is a positive finding.

5. **Lymph Node Involvement**: The absence of lymph node involvement is a favorable prognostic factor, as lymph node metastasis is often associated with a worse prognosis.

6. **Further Mutation Analysis**: The recommendation for further mutation analysis for EGFR and KRAS suggests that targeted therapy options may be available, which could improve the patient's prognosis if actionable mutations are found.

Considering these factors, the small tumor size, clear surgical margins, and absence of lymph node involvement are positive indicators for survival. The moderately to poorly differentiated grade and focal lymphatic invasion are potential concerns, but they are not definitive indicators of poor prognosis in the absence of lymph node involvement. Therefore, the overall prognosis appears to be cautiously optimistic.

Answer - {""Survival"": ""True""}"
14,"1. **Tumor Characteristics**: The adenocarcinoma is acinar type, grade III, which indicates a poorly differentiated tumor. Poor differentiation is generally associated with a more aggressive cancer and a worse prognosis.

2. **Tumor Size and Invasion**: The tumor measures 4 cm and invades the visceral pleura. Pleural invasion can be associated with a more advanced disease and potentially worse outcomes.

3. **Margins**: The bronchial and vascular margins are negative, which is a positive factor as it suggests that the tumor has been completely resected in those areas.

4. **Lymph Node Involvement**: Metastatic adenocarcinoma was identified in two of four lymph nodes examined. This indicates regional lymph node involvement, which is a negative prognostic factor.

5. **Staging**: The cancer is staged as pT2, N2, Mx. The T2 stage indicates a tumor size of more than 3 cm but less than 5 cm, with pleural invasion. N2 indicates metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes, which is associated with a more advanced stage of cancer. Mx indicates that distant metastasis cannot be assessed.

6. **Overall Prognosis**: The presence of lymph node metastasis (N2) and pleural invasion, combined with the poorly differentiated nature of the tumor, suggests a more advanced and aggressive cancer. The staging of pT2, N2, Mx typically corresponds to a stage III cancer, which generally has a poorer prognosis and lower survival rates.

Based on these factors, the likelihood of survival after 2.48 years is low.

Answer - {""Survival"": ""False""}"
15,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Tumor Characteristics**: The report indicates an invasive moderately differentiated adenocarcinoma measuring 9.2 cm. The size and differentiation level suggest a significant tumor burden, but not the most aggressive form.

2. **Invasion**: The tumor has invaded the chest wall, which is a concerning feature as it indicates more advanced local disease. However, the surgical margins are negative, meaning the tumor was completely resected, which is a positive prognostic factor.

3. **Lymph Node Involvement**: All 19 examined peribronchial lymph nodes are negative for carcinoma, indicating no regional lymph node metastasis. This is a favorable finding as lymph node involvement often correlates with worse outcomes.

4. **Pathological Staging**: The tumor is staged as pT3. This stage indicates a larger tumor that has invaded nearby structures (such as the chest wall), but without lymph node involvement (N0) or distant metastasis (M0), which is not mentioned in the report.

5. **Additional Findings**: Chronic inflammation and emphysematous changes are noted in the non-neoplastic lung tissue, which may affect overall lung function but are not directly related to cancer prognosis.

Considering these factors, the absence of lymph node involvement and negative surgical margins are positive indicators. However, the chest wall invasion and the size of the tumor are concerning. The prognosis is mixed, but given the absence of lymph node metastasis and complete resection, there is a reasonable chance of survival beyond 2.48 years.

Answer - {""Survival"": ""True""}"
16,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Diagnosis**: The patient has lung adenocarcinoma, which is a type of non-small cell lung cancer.

2. **Tumor Characteristics**: The adenocarcinoma is moderately differentiated and measures 6.9 cm. There is visceral pleural invasion and lymphangitic invasion, indicating aggressive behavior.

3. **Lymph Node Involvement**: Metastatic adenocarcinoma was identified in lymph nodes from the left level 9 and two out of five lymph nodes from the left level 11. This indicates regional lymph node involvement.

4. **Distant Metastasis**: No distant metastasis was noted in the report, which is a positive factor for prognosis.

5. **Overall Staging**: The presence of regional lymph node involvement and visceral pleural invasion suggests at least stage III disease, which is associated with a poorer prognosis compared to earlier stages.

Considering these factors, the presence of regional lymph node involvement and visceral pleural invasion, along with the size of the tumor, suggests a more advanced stage of lung cancer. While there is no distant metastasis, the regional spread and aggressive features of the tumor indicate a challenging prognosis.

Based on these considerations, the likelihood of survival after 2.48 years is less favorable.

Answer - {""Survival"": ""False""}"
17,"The pathology report provided lacks specific diagnostic information about the tumor type, size, grade, stage, or any other relevant pathological findings that would allow for an assessment of the patient's prognosis or survival likelihood. Without this critical information, it is impossible to make an informed determination about the patient's survival after 2.48 years.

Answer - {""Survival"": ""False""}"
18,"To determine if the patient will survive after 2.48 years based on the provided pathology report, let's analyze the key details:

1. **Diagnosis and Tumor Characteristics**:
   - The patient has a well-differentiated papillary non-mucinous adenocarcinoma in the right lower lobe.
   - The tumor measures 50 mm and extends to the visceral pleura, but the pleura is tumor-free.

2. **Tumor Classification and Staging**:
   - The tumor is classified as M-8140/3, G1, which indicates a well-differentiated adenocarcinoma.
   - Staging is pT2, pN0, pMX, and stage I B:
     - pT2: Tumor size and/or local extent is significant but not beyond the visceral pleura.
     - pN0: No regional lymph node involvement.
     - pMX: Distant metastasis cannot be assessed, but no evidence of metastasis is noted.
     - Stage I B: Early-stage cancer with no lymph node involvement or distant metastasis.

3. **Resection Margins and Additional Findings**:
   - Resection margins are clear of tumor (R0), indicating complete surgical removal.
   - Additional findings include subpleural scarring and pleural adhesions, which are not indicative of metastasis or aggressive disease.

4. **Prognosis Considerations**:
   - Well-differentiated tumors generally have a better prognosis compared to poorly differentiated ones.
   - The absence of lymph node involvement (pN0) and clear resection margins (R0) are positive prognostic factors.
   - Stage I B cancer typically has a favorable prognosis with appropriate treatment.

Based on these factors, the patient is likely to have a favorable prognosis and a good chance of survival beyond 2.48 years, assuming appropriate treatment and follow-up care.

Answer - {""Survival"": ""True""}"
19,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Tumor Characteristics**: The report describes a poorly differentiated adenocarcinoma, which generally indicates a more aggressive tumor with a worse prognosis compared to well-differentiated tumors.

2. **Tumor Size and Invasion**: The tumor measures 4.5 cm and shows visceral pleural and lymphovascular invasion. The presence of invasion into the pleura and lymphovascular structures suggests a more advanced and aggressive disease.

3. **Lymph Node Involvement**: Although most excised lymph nodes show no evidence of metastatic carcinoma, one of the six lymph nodes examined contains metastatic carcinoma with extracapsular extension. This indicates that the cancer has spread beyond the primary tumor site, which is a negative prognostic factor.

4. **Staging**: The tumor is staged as pT2aN1MX. The T2a stage indicates a tumor size between 3 and 5 cm with certain invasive characteristics. N1 indicates regional lymph node involvement, which is associated with a higher risk of recurrence and poorer prognosis. MX means that distant metastasis cannot be assessed, leaving uncertainty about the presence of metastasis elsewhere in the body.

Given these factors, the presence of poorly differentiated histology, lymphovascular invasion, pleural involvement, and lymph node metastasis with extracapsular extension all suggest a more aggressive cancer with a higher risk of recurrence and poorer prognosis. Therefore, the likelihood of survival after 2.48 years is lower.

Answer - {""Survival"": ""False""}"
20,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, we need to consider several factors typically associated with prognosis in lung cancer:

1. **Tumor Differentiation**: The report indicates a poorly differentiated bronchiolo-alveolar adenocarcinoma. Poor differentiation generally suggests a more aggressive tumor, which can be associated with a worse prognosis.

2. **Tumor Size**: The tumor measures 2.5 x 1.5 x 3 cm. This size is relatively small, which might suggest a better prognosis if the disease is localized.

3. **Extent of Disease**: The report lacks details on tumor extent, presence of other nodules, lymph node involvement, and invasion. These are critical factors in staging and determining prognosis. Without this information, it's challenging to accurately assess the stage of the cancer.

4. **Lymph Node Involvement and Metastasis**: The absence of information on lymph node involvement or distant metastasis makes it difficult to determine the stage. Typically, the absence of lymph node involvement and metastasis would suggest a better prognosis.

5. **Additional Findings**: There are no additional findings or comments in the report, which limits the ability to assess other potential prognostic factors.

Given the limited information, particularly the lack of details on lymph node involvement and metastasis, it is challenging to make a definitive prediction. However, the presence of poorly differentiated adenocarcinoma suggests a potentially aggressive disease, which could negatively impact survival.

Considering these factors, and the general principle that poorly differentiated tumors have a worse prognosis, the likelihood of survival after 2.48 years may be lower.

Answer - {""Survival"": ""False""}"
21,"The pathology report provides the following key details:

1. **Tumor Characteristics**: The tumor is a moderately-differentiated adenocarcinoma, which generally indicates a better prognosis compared to poorly differentiated tumors.

2. **Tumor Size**: The tumor measures 2.5 cm, which is relatively small and suggests an early stage of cancer.

3. **Margins**: The surgical margins are negative, indicating that the tumor has been completely resected with no residual cancerous tissue at the edges of the removed tissue.

4. **Vascular and Lymphatic Invasion**: There is no evidence of vascular or lymphatic invasion, which is a positive prognostic factor as it suggests the cancer has not spread through these pathways.

5. **Lymph Nodes**: All examined regional lymph nodes (five in total) are negative for malignancy, indicating no lymph node involvement, which is a favorable prognostic indicator.

6. **Pleural Invasion**: The tumor shows invasion towards the pleural surface but does not directly involve the visceral pleura. This suggests limited pleural involvement, which is less concerning than direct invasion.

Based on these factors, the prognosis appears favorable. The tumor is small, well-contained, and there is no evidence of spread to lymph nodes or through vascular/lymphatic pathways. The absence of direct visceral pleural involvement further supports a positive outlook.

Therefore, the likelihood of survival after 2.48 years is high.

Answer - {""Survival"": ""True""}"
22,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Metastatic Carcinoma in Multiple Lymph Nodes**: The presence of metastatic carcinoma in multiple lymph nodes is a significant indicator of advanced disease. Lymph node involvement generally suggests a poorer prognosis due to the potential for further spread of the cancer.

2. **Poorly Differentiated Adenocarcinoma**: Poor differentiation in adenocarcinoma is associated with a more aggressive tumor and a worse prognosis compared to well-differentiated tumors.

3. **Tumor Size**: The primary tumor size is 1.7 cm, which is relatively small. However, the size is less critical in this context due to the presence of metastatic disease.

4. **Capsular Penetration and Lymphatic Invasion**: These findings indicate aggressive tumor behavior and further support the likelihood of systemic disease spread.

5. **Negative Surgical Margins**: While negative surgical margins are generally a positive finding, indicating that the tumor was completely resected, the presence of metastatic disease in lymph nodes overshadows this benefit.

6. **Exclusion of Breast Carcinoma as Source**: This confirms the primary site as pulmonary, which is relevant for treatment planning but does not directly impact the survival prognosis.

Given these factors, particularly the metastatic involvement of multiple lymph nodes and the poorly differentiated nature of the tumor, the prognosis is poor. Therefore, the likelihood of survival after 2.48 years is low.

Answer - {""Survival"": ""False""}"
23,"The pathology report provides the following key details:

1. **Lymph Nodes**: All excised lymph nodes, including those at levels IX and XI, are negative for malignancy. This indicates no lymph node involvement, which is a positive prognostic factor.

2. **Tumor Characteristics**: The tumor is a moderately differentiated adenocarcinoma, measuring 2.0 cm. Moderate differentiation generally suggests a better prognosis compared to poorly differentiated tumors.

3. **Surgical Margins**: The surgical margins are clear, meaning the tumor was completely excised with no residual cancerous tissue left behind.

4. **Pleural Involvement**: There is no pleural involvement, which is another positive factor as pleural invasion can indicate a more advanced disease and worse prognosis.

5. **Metastasis**: There is no evidence of metastasis in the examined lymph nodes, suggesting the cancer is localized.

Given these findings, the patient has a localized lung adenocarcinoma with no lymph node involvement, clear surgical margins, and no pleural invasion. These factors collectively suggest a favorable prognosis and a higher likelihood of survival beyond 2.48 years.

Answer - {""Survival"": ""True""}"
24,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key details:

1. **Tumor Size and Classification**: The tumor is 6.5 x 6.5 x 5.0 cm, classified as pT2b. This indicates a relatively large tumor but still within a range that is considered potentially resectable.

2. **Lymph Node Involvement**: The classification pN1 (6/28) indicates that there is involvement of regional lymph nodes, with 6 out of 28 lymph nodes showing metastasis. Lymph node involvement is a negative prognostic factor, as it suggests some spread of the cancer beyond the primary tumor site.

3. **Metastasis**: The classification pMx indicates that distant metastasis cannot be assessed. This leaves some uncertainty regarding the presence of distant spread, which is a critical factor in prognosis.

4. **Histological Grade**: The tumor is graded as G3, which means it is poorly differentiated. Poorly differentiated tumors tend to have a worse prognosis due to their aggressive nature.

5. **Immunohistochemical Markers**: The tumor cells are positive for CK7, which is common in lung adenocarcinomas, and have a Ki-67 proliferation index of 40%. A high Ki-67 index suggests a high rate of cell proliferation, which is often associated with more aggressive tumors.

Considering these factors:
- The presence of lymph node involvement (pN1) and a high Ki-67 index are significant negative prognostic indicators.
- The tumor is poorly differentiated (G3), which also suggests a more aggressive disease course.
- The lack of visceral pleura infiltration is a positive factor, but the overall prognosis is more heavily influenced by the lymph node involvement and high proliferation index.

Given these considerations, the likelihood of survival beyond 2.48 years is reduced due to the aggressive nature of the tumor and lymph node involvement.

Answer - {""Survival"": ""False""}"
25,"1. **Diagnosis and Tumor Characteristics**: The patient has metastatic adenocarcinoma, which indicates that the cancer has spread beyond the primary site. The tumor is moderately to poorly differentiated, which generally suggests a more aggressive cancer.

2. **Lymph Node Involvement**: Eight out of twelve lymph nodes from the left lung are positive for cancer, and additional lymph nodes are also affected. This extensive lymph node involvement is a poor prognostic factor.

3. **Lymphovascular Invasion**: The presence of lymphovascular invasion indicates that the cancer has the potential to spread through the lymphatic system and blood vessels, further worsening the prognosis.

4. **Direct Extension**: The tumor has direct extension into two intraparenchymal lymph nodes, which suggests aggressive local spread.

5. **Molecular Analysis**: No EGFR mutations were detected, which may limit the effectiveness of certain targeted therapies. The presence of a polymorphism of uncertain clinical significance does not provide any clear therapeutic advantage or disadvantage.

6. **Overall Prognosis**: Given the metastatic nature of the adenocarcinoma, extensive lymph node involvement, lymphovascular invasion, and lack of actionable EGFR mutations, the prognosis is poor. The likelihood of survival beyond 2.48 years is low.

Answer - {""Survival"": ""False""}"
26,"The pathology report provides the following key details:

1. **Tumor Characteristics**: The invasive adenocarcinoma is located in the left upper lobe of the lung, with a size of 3.5 cm and a histologic grade of 2/4. There is no invasion of the visceral pleura or large vessels, which is a positive prognostic factor.

2. **Lymph Node Involvement**: Multiple lymph nodes were examined, and the majority showed no tumor presence. However, hilar node #2 contained metastatic adenocarcinoma, indicating some lymph node involvement.

3. **TNM Staging**: The tumor is staged as pT2a, pN1, pMX. The pT2a indicates a tumor size greater than 3 cm but less than or equal to 5 cm, with no invasion into the visceral pleura or main bronchus. The pN1 indicates metastasis to ipsilateral peribronchial and/or hilar lymph nodes and intrapulmonary nodes, which is a factor that can affect prognosis. The pMX indicates that distant metastasis cannot be assessed.

4. **Resection Margins**: The resection margins are clear of tumor, which is a favorable factor as it suggests that the tumor was completely removed.

Considering these factors, the presence of lymph node involvement (pN1) is a concern, as it can affect survival rates. However, the absence of visceral pleura or large vessel invasion, clear resection margins, and the fact that the majority of lymph nodes are negative for tumor are positive indicators. The prognosis is not as favorable as it would be without lymph node involvement, but it is not necessarily poor.

Given the information provided, the patient has a reasonable chance of survival beyond 2.48 years, although the lymph node involvement does introduce some risk.

Answer - {""Survival"": ""True""}"
27,"The pathology report presents the following key findings:

1. **Diagnosis**: Adenocarcinoma in the left upper lobe of the lung with components of solid, acinar, and bronchioloalveolar cell carcinoma.
2. **Tumor Size**: Measures 3.5 x 2.8 x 2.5 cm.
3. **Metastasis**: Evidence of metastatic adenocarcinoma in peribronchial lymph nodes.
4. **Invasion**: Invades the visceral pleura, no vascular invasion, lymphatic invasion pending.
5. **Additional Findings**: Centrilobular emphysema, pulmonary hemosiderosis, necrotizing granulomas in lymph nodes, negative results for neoplasm in some lymph nodes.

**Analysis**:

- The presence of metastatic adenocarcinoma in peribronchial lymph nodes indicates that the cancer has spread beyond the primary tumor site, which is a negative prognostic factor.
- The invasion of the visceral pleura suggests a more advanced local disease, which can also negatively impact prognosis.
- The absence of vascular invasion is a positive factor, but the pending status of lymphatic invasion leaves some uncertainty.
- The additional findings (centrilobular emphysema, pulmonary hemosiderosis, necrotizing granulomas) do not directly impact the prognosis of the adenocarcinoma but indicate other lung conditions that may affect overall health.

Given the evidence of metastatic spread to lymph nodes and pleural invasion, the prognosis is likely poor, and survival beyond 2.48 years is uncertain.

**Conclusion**: Based on the metastatic involvement of lymph nodes and pleural invasion, the likelihood of survival beyond 2.48 years is low.

Answer - {""Survival"": ""False""}"
28,"To determine the likelihood of survival after 2.48 years based on the pathology report, let's analyze the key findings:

1. **Tumor Characteristics**: The tumor is a poorly differentiated adenocarcinoma, which generally indicates a more aggressive cancer with a poorer prognosis compared to well-differentiated tumors.

2. **Size and Location**: The tumor measures 58 mm and is located in the right upper lobe of the lung. The size is relatively large, which can be associated with a more advanced stage.

3. **Invasion**: There is visceral pleural invasion and involvement of the chest wall. Visceral pleural invasion is a negative prognostic factor as it indicates that the tumor has breached the lung's protective lining. Chest wall involvement further suggests a more advanced local spread.

4. **Margins**: The bronchial resection margin is clear, which is a positive factor as it indicates that the surgical removal of the tumor was complete in that area.

5. **Vascular Invasion**: There is evidence of blood vessel invasion, which is a negative prognostic factor as it suggests potential for hematogenous spread (spread through the bloodstream).

6. **Lymphatic and Perineural Invasion**: There is no lymphatic or perineural invasion, which is a positive factor as it indicates that the cancer has not spread through these pathways.

7. **Lymph Node Metastasis**: No lymph node metastases were found, which is a positive prognostic factor as it suggests that the cancer has not spread to the lymphatic system.

8. **Chest Wall and Rib Examination**: No residual malignancy was found in the chest wall tissues or rib bone, which is a positive factor indicating that the cancer has not spread to these areas.

Considering these factors, the presence of visceral pleural invasion, chest wall involvement, and vascular invasion are significant negative prognostic indicators. However, the absence of lymph node metastasis and clear surgical margins are positive factors. Given the aggressive nature of poorly differentiated adenocarcinoma and the presence of vascular invasion, the overall prognosis is likely poor.

Answer - {""Survival"": ""False""}"
29,"To determine the likelihood of survival after 2.48 years based on the pathology report, let's analyze the key details:

1. **Tumor Differentiation**: The tumor is described as poorly differentiated adenocarcinoma. Poor differentiation generally indicates a more aggressive tumor, which can be associated with a worse prognosis.

2. **Tumor Size**: The tumor measures 3.5 x 3 cm. This size is relatively small, which is generally favorable for prognosis, especially if the tumor is localized.

3. **Venous Invasion**: There is no evidence of venous invasion. The absence of venous invasion is a positive factor, as venous invasion can facilitate the spread of cancer cells.

4. **Lymph Node Involvement**: Seven hilar lymph nodes were examined, and all showed reactive changes but were negative for metastasis. The absence of lymph node metastasis is a very positive prognostic factor, as lymph node involvement often indicates a higher risk of recurrence and spread.

5. **Surgical Margins**: The surgical margins are uninvolved, suggesting that the tumor was completely resected. Complete resection with clear margins is a critical factor in improving survival outcomes.

Considering these factors, despite the poor differentiation of the tumor, the absence of lymph node involvement, venous invasion, and the complete resection with clear margins are strong positive indicators for survival. Therefore, the likelihood of survival after 2.48 years is favorable.

Answer - {""Survival"": ""True""}"
30,"1. **Tumor Characteristics**: The primary tumor is a solid predominant adenocarcinoma measuring 3.7 cm. This size is relatively small, which is generally favorable for prognosis.

2. **Stage**: The tumor is classified as Stage IIB. Stage IIB indicates a more advanced local disease but without distant metastasis. This stage can have a variable prognosis depending on other factors.

3. **Lymph Node Involvement**: All 11 examined lymph nodes are negative for cancer, which is a positive prognostic factor as it indicates no regional spread.

4. **Invasion**: There is no visceral pleural invasion or lymph-vascular invasion identified, which are both favorable factors for survival.

5. **Molecular Studies**: No EGFR mutations were detected. While the absence of EGFR mutations might limit certain targeted therapies, it does not necessarily indicate a poor prognosis on its own.

6. **Overall Assessment**: The absence of lymph node involvement, lack of invasion, and relatively small tumor size are positive indicators. Although Stage IIB suggests a more advanced local disease, the lack of metastasis and other favorable factors suggest a reasonable chance of survival beyond 2.48 years.

Based on these considerations, the patient is likely to survive beyond 2.48 years.

Answer - {""Survival"": ""True""}"
31,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Diagnosis and Tumor Characteristics**:
   - The patient has a poorly differentiated adenocarcinoma, which is a type of non-small cell lung carcinoma (NSCLC).
   - The tumor size is 3.5 cm, which is relatively small but significant.

2. **Invasion**:
   - There is evidence of invasion into the visceral pleura and large vessels. This indicates a more aggressive tumor behavior and potential for spread.

3. **Lymph Node Involvement**:
   - Metastases are present in the ipsilateral peribronchial and hilar lymph nodes. This suggests regional spread of the cancer, which is a negative prognostic factor.
   - Multiple lymph node biopsies from various stations were negative for malignancy, indicating no distant lymph node involvement.

4. **Margins**:
   - The bronchial margins are free of tumor, with a 5 mm distance from the invasive carcinoma to the closest margin. This is a positive finding, as it suggests complete resection of the tumor.

5. **Overall Staging and Prognosis**:
   - The presence of lymph node metastases and invasion into the visceral pleura and large vessels suggests at least stage II or III disease, depending on the exact staging criteria used.
   - Poor differentiation and lymph node involvement generally indicate a poorer prognosis.

Considering these factors, the presence of lymph node metastases and invasion into critical structures like the visceral pleura and large vessels are significant negative prognostic indicators. While the tumor has been resected with clear margins, the overall prognosis is likely poor due to the aggressive nature of the disease and regional spread.

Therefore, the likelihood of survival after 2.48 years is low.

Answer - {""Survival"": ""False""}"
32,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Tumor Characteristics**: The tumor is a poorly differentiated adenocarcinoma measuring 2.5 cm. Poor differentiation generally indicates a more aggressive tumor, which can be associated with a worse prognosis.

2. **Surgical Margins**: The surgical margins are uninvolved, which is a positive factor as it suggests that the tumor was completely resected.

3. **Visceral Pleural Invasion**: There is a suggestion of visceral pleural invasion. Pleural invasion can be associated with a higher stage of cancer and may negatively impact prognosis.

4. **Residual Malignancy**: The right lower lobe lobectomy showed no residual malignancy, which is a positive finding indicating that the primary tumor was likely completely removed.

5. **Lymph Node Involvement**: Among the examined lymph nodes, only the level 12 nodes demonstrated evidence of metastasis. The presence of lymph node metastasis, even if limited, can indicate a higher stage of cancer and may negatively impact prognosis.

6. **Other Lymph Nodes**: The other lymph nodes showed no metastatic involvement, which is a positive factor.

Considering these factors, the presence of poorly differentiated adenocarcinoma and lymph node metastasis (even if limited) suggests a more aggressive disease. However, the complete resection of the primary tumor and the lack of residual malignancy are positive factors. The presence of metastasis in the level 12 lymph nodes is concerning, but the overall findings suggest that the disease may be controlled with appropriate treatment.

Based on the balance of these factors, the likelihood of survival after 2.48 years is cautiously optimistic, but the presence of lymph node metastasis introduces some uncertainty.

Answer - {""Survival"": ""True""}"
33,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Tumor Characteristics**: The tumor is a poorly differentiated adenocarcinoma measuring 3.5 cm. Poor differentiation generally indicates a more aggressive tumor, which can negatively impact prognosis.

2. **Pleural Invasion**: The tumor invades the pleura. Pleural invasion is associated with a higher stage of cancer and can be a negative prognostic factor.

3. **Surgical Margins**: The surgical margins are negative for tumor, which is a positive factor as it suggests that the tumor was completely resected.

4. **Vascular Invasion**: The presence of vascular invasion is a negative prognostic factor as it indicates that the cancer has the potential to spread through blood vessels.

5. **Lymph Node Involvement**: There is no evidence of regional lymph node involvement, which is a positive factor as lymph node metastasis is a significant negative prognostic indicator.

6. **Distant Metastasis**: There is no evidence of distant metastasis, which is a positive factor as distant metastasis significantly worsens prognosis.

Considering these factors, the presence of vascular invasion and pleural invasion are concerning for potential spread and recurrence, which negatively impacts prognosis. However, the absence of lymph node involvement and distant metastasis, along with negative surgical margins, are positive factors. Given the balance of these factors, the prognosis is uncertain but leans towards a poorer outcome due to the aggressive nature of the tumor and vascular invasion.

Answer - {""Survival"": ""False""}"
34,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Tumor Characteristics**: The report describes a 2.8 cm invasive moderately differentiated adenocarcinoma. Moderate differentiation generally indicates an intermediate prognosis compared to well-differentiated (better prognosis) and poorly differentiated (worse prognosis) tumors.

2. **Invasion**: There is angiolymphatic and visceral pleural invasion. Angiolymphatic invasion can be a negative prognostic factor as it suggests potential for metastasis. Visceral pleural invasion also indicates a more aggressive tumor behavior.

3. **Lymph Nodes**: All sampled lymph nodes are benign, which is a positive finding. The absence of lymph node metastasis (N0) is generally associated with a better prognosis.

4. **Surgical Margins**: The surgical resection margins are free of tumor, indicating that the tumor was completely resected, which is a favorable factor for survival.

5. **Pathologic Stage**: The tumor is classified as T2N0MX. T2 indicates a tumor size greater than 3 cm but less than 5 cm or a tumor with certain invasive characteristics. N0 indicates no regional lymph node metastasis. MX means distant metastasis cannot be assessed, but there is no evidence provided of distant metastasis in the report.

6. **Additional Findings**: Chronic inflammation, submucosal scarring, and emphysematous changes are noted, but these are not directly related to the cancer prognosis.

Considering these factors, the absence of lymph node involvement and clear surgical margins are positive indicators for survival. However, the presence of angiolymphatic and visceral pleural invasion introduces some risk. Overall, the prognosis seems cautiously optimistic given the complete resection and lack of lymph node involvement.

Answer - {""Survival"": ""True""}"
35,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key details:

1. **Diagnosis**: The patient has a poorly differentiated non-small cell carcinoma originating from the lung. Poor differentiation generally indicates a more aggressive tumor, which can be associated with a worse prognosis.

2. **Tumor Size and Unifocality**: The tumor measures 5.5 x 5.0 cm and is unifocal. While the size is significant, the fact that it is unifocal (a single tumor) is somewhat favorable compared to multifocal disease.

3. **Immunohistochemical Staining**: The tumor is positive for TTF-1 and negative for p63, CK5/6, CK7, and CK20. This profile supports the diagnosis of adenocarcinoma, which is a common type of non-small cell lung cancer.

4. **Lymph Node Involvement**: All examined lymph nodes are negative for carcinoma. The absence of lymph node involvement is a positive prognostic factor, as it suggests that the cancer has not spread to these regions.

5. **Further Characterization Pending**: Additional immunoevaluation is pending, which may provide more insights into the tumor's behavior and potential treatment options.

Considering these factors, the absence of lymph node involvement is a significant positive indicator for survival. Although the tumor is poorly differentiated, the lack of metastatic spread to lymph nodes suggests a localized disease, which generally has a better prognosis.

Based on the information provided, the likelihood of survival after 2.48 years is more favorable, leading to the conclusion:

Answer - {""Survival"": ""True""}"
36,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Tumor Characteristics**: The report describes a poorly differentiated adenocarcinoma with clear cell changes, measuring 7 cm. Poor differentiation generally indicates a more aggressive tumor, but the size alone does not determine prognosis.

2. **Visceral Pleura Invasion**: There is no invasion of the visceral pleura, which is a positive prognostic factor as pleural invasion can indicate a more advanced disease.

3. **Margins**: The bronchial and vascular margins are negative, meaning the tumor was completely resected with no residual cancer at the edges of the removed tissue. This is a favorable finding as it suggests that the cancer has been fully removed.

4. **Lymph Nodes**: All examined lymph nodes from levels 4, 7, and 9 show no evidence of tumor. The absence of lymph node involvement is a significant positive prognostic factor, as lymph node metastasis is associated with a higher risk of recurrence and poorer outcomes.

5. **Sixth Rib**: The portion of the sixth rib examined also shows no evidence of tumor, indicating no local spread to the bone.

Overall, the pathology report suggests a successful surgical resection of the lung cancer with clear margins and no metastatic spread to the sampled lymph nodes or other structures. Despite the poor differentiation of the tumor, the lack of pleural invasion, negative margins, and absence of lymph node involvement are strong indicators of a favorable prognosis.

Based on these findings, it is reasonable to conclude that the patient has a good chance of surviving beyond 2.48 years.

Answer - {""Survival"": ""True""}"
37,"To determine the likelihood of survival after 2.48 years based on the provided pathology report, let's analyze the key findings:

1. **Tumor Type and Size**: The report describes a mixed acinar and bronchioloalveolar adenocarcinoma measuring 3.5 cm. The tumor is moderately to poorly differentiated, which generally indicates a more aggressive cancer with a potentially worse prognosis compared to well-differentiated tumors.

2. **Lymph Node Involvement**: Metastatic adenocarcinoma was found in one of two resected lymph nodes. Lymph node involvement is a significant factor in cancer staging and prognosis, as it suggests that the cancer has started to spread beyond the primary site.

3. **KRAS Mutation**: The presence of a KRAS mutation, particularly in codon 12 or 13, is associated with a poorer prognosis and can indicate resistance to certain therapies, such as EGFR inhibitors. This mutation is often linked to more aggressive disease and reduced survival rates.

4. **Other Findings**: The remaining lymph nodes and associated fibroadipose tissue were negative for tumor, which is a positive finding, but the presence of metastatic disease in even one lymph node is concerning.

Considering these factors, the presence of a KRAS mutation, lymph node metastasis, and the moderate to poorly differentiated nature of the tumor suggest a more aggressive cancer with a potentially poorer prognosis. Therefore, the likelihood of survival after 2.48 years is less favorable.

Answer - {""Survival"": ""False""}"
